Ratti, Emiliangelo

Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression

Felger, J. C., Alagbe, O., Hu, F., Mook, D., Freeman, A. A., Sanchez, M. M., Kalin, N. H., Ratti, E., Nemeroff, C. B., & Miller, A. H. (2007) · Biological Psychiatry

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 214

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.

Burns, D. K., Alexander, R. C., Welsh-Bohmer, K. A., Culp, M., Chiang, C., O’Neil, J., Evans, R. M., Harrigan, P., Plassman, B. L., Burke, J. R., et al. (2021) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 130

Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies

Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., et al. (2013) · Journal of Psychopharmacology

Treatment of Major DepressionNeuropeptides and Animal Physiology

Cited by 69

Differential Effects of the CRF-R1 Antagonist GSK876008 on Fear-Potentiated, Light- and CRF-Enhanced Startle Suggest Preferential Involvement in Sustained vs Phasic Threat Responses

Walker, D., Yang, Y., Ratti, E., Corsi, M., Trist, D., & Davis, M. (2009) · Neuropsychopharmacology

Memory and Neural MechanismsNeuropeptides and Animal Physiology

Cited by 69

The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families

Prandini, P., Pasquali, A., Malerba, G., Marostica, A., Zusi, C., Xumerle, L., Muglia, P., Da Ros, L., Ratti, E., Trabetti, E., et al. (2012) · Psychiatric Genetics

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 41

Synthesis and Pharmacological Characterization of Novel Druglike Corticotropin-Releasing Factor 1 Antagonists

Fabio, R. D., St-Denis, Y., Sabbatini, F. M., Andreotti, D., Arban, R., Bernasconi, G., Braggio, S., Blaney, F. E., Capelli, A. M., Castiglioni, E., et al. (2008) · Journal of Medicinal Chemistry

Heterocyclic Compound Synthesis and BioactivityNeuropeptides and Animal Physiology

Cited by 34